Verona Pharma plc

News & Events

Press Releases

In The Media

1. Verona Pharma Announces June 2025 Investor Conference Participation

   GlobeNewswire MAY 21, 2025 6:00 AM EDT
   LONDON and RALEIGH, N.C., May 21, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (...
   READ ARTICLE

2. Verona Pharma to Present Seven Analyses of the Phase 3 ENHANCE Studies in COPD at ATS 2025

   GlobeNewswire MAY 6, 2025 6:00 AM EDT
   Analyses support Ohtuvayre® (ensifentrine) as a first-in-class selective dual inhibitor of...
   READ ARTICLE

3. Verona Pharma Reports First Quarter 2025 Financial Results and Provides Corporate Update

   GlobeNewswire APR 29, 2025 6:00 AM EDT
   Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre ® net sa...
   READ ARTICLE

4. Verona Pharma to Report First Quarter 2025 Financial Results and Provide Corporate Update

   GlobeNewswire APR 15, 2025 6:00 AM EDT
   LONDON and RALEIGH, N.C., April 15, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (&#...
   READ ARTICLE

5. Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS

   GlobeNewswire MAR 28, 2025 7:00 AM EDT
   RIPSA interests repurchased Term loan facility increased to $450 million with more favora...
   READ ARTICLE

6. Verona Pharma Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

   GlobeNewswire FEB 27, 2025 6:00 AM EST
   Ohtuvayre TM (ensifentrine) recorded net product sales of $36.6 million in Q4 and $42...
   READ ARTICLE

7. Verona Pharma Announces March 2025 Investor Conference Participation

   GlobeNewswire FEB 18, 2025 6:00 AM EST
   LONDON and RALEIGH, N.C., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (&#x...
   READ ARTICLE

8. Verona Pharma to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Corporate Update

   GlobeNewswire FEB 13, 2025 6:00 AM EST
   LONDON and RALEIGH, N.C., Feb. 13, 2025 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (&#x...
   READ ARTICLE

9. Verona Pharma Reports Strong Ohtuvayre(TM) Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

   GlobeNewswire JAN 7, 2025 6:00 AM EST
   Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter a...
   READ ARTICLE

10. Verona Pharma Announces December 2024 Investor Conference Participation

    GlobeNewswire NOV 19, 2024 2:00 AM EST
    LONDON and RALEIGH, N.C., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (&#x...
    READ ARTICLE